Related Experiment Video
Updated: Feb 4, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Novel pathogenic variants in filamin C identified in pediatric restrictive cardiomyopathy
Jeffrey Schubert1,2, Muhammad Tariq3, Gabrielle Geddes4
1Department of Molecular Genetics, Microbiology, and Biochemistry, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Insights
Genetic variants in the filamin C (FLNC) gene are linked to restrictive cardiomyopathy (RCM) in children. This finding expands the known genetic causes of RCM and highlights FLNC for early-onset cardiomyopathy genetic testing.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Diseases
Background:
- Restrictive cardiomyopathy (RCM) is a rare cardiac condition defined by impaired diastolic function with normal ventricular size and systolic function.
- Genetic underpinnings of RCM, particularly in early-onset cases, remain largely unidentified.
- Previous studies implicated sarcomeric and cytoskeletal genes, but a significant portion of RCM cases lack a clear genetic diagnosis.
Purpose of the Study:
- To investigate the genetic basis of restrictive cardiomyopathy (RCM) in two families with childhood-onset disease.
- To identify novel gene variants associated with autosomal dominant RCM and RCM in twins.
- To elucidate the role of filamin C (FLNC) in the pathogenesis of pediatric RCM.
Main Methods:
- Whole exome sequencing was performed on affected individuals from two distinct RCM families.
- Segregation analysis was conducted to confirm the inheritance pattern of identified variants.
- In vitro functional studies using C2C12 myoblast cells were employed to assess the impact of mutant FLNC proteins.
Main Results:
- Pathogenic variants in the filamin C (FLNC) gene were identified in both families: p.Pro2298Leu in the autosomal dominant family and p.Tyr2563Cys in the affected twins.
- Both identified FLNC variants segregated with the disease phenotype within their respective families.
- In vitro expression studies revealed that mutant FLNC proteins formed aggregates with actin in muscle cells, suggesting a mechanism for cellular dysfunction.
Conclusions:
- The study provides strong evidence implicating filamin C (FLNC) gene variants in the etiology of pediatric restrictive cardiomyopathy (RCM).
- These findings expand the spectrum of cardiomyopathies associated with FLNC mutations.
- Genetic testing for FLNC variants should be considered in the diagnostic workup of children presenting with RCM, especially those with early onset.
Abstract:
Restrictive cardiomyopathy (RCM) is a rare and distinct form of cardiomyopathy characterized by normal ventricular chamber dimensions, normal myocardial wall thickness, and preserved systolic function. The abnormal myocardium, however, demonstrates impaired relaxation. To date, dominant variants causing RCM have been reported in a small number of sarcomeric or cytoskeletal genes, but the genetic causes in a majority of cases remain unexplained, especially in early childhood. Here, we describe two RCM families with childhood onset: one in a large family with a history of autosomal dominant RCM and the other a family with affected monozygotic, dichorionic/diamniotic twins. Exome sequencing found a pathogenic filamin C (FLNC) variant in each: p.Pro2298Leu, which segregates with disease in the large autosomal dominant RCM family, and p.Tyr2563Cys in both affected twins. In vitro expression of both mutant proteins yielded aggregates of FLNC containing actin in C2C12 myoblast cells. Recently, a number of variants in FLNC have been described that cause hypertrophic, dilated, and restrictive cardiomyopathies. Our data presented here provide further evidence for the role of FLNC in pediatric RCM, and suggest the need to include FLNC in genetic testing of cardiomyopathy patients including those with early ages of onset.
More Related Videos
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Histone Variants at the Centromere
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Cardiomyopathy V: Interprofessional Care

